News
2 minute read

MBHB Partner Kevin Noonan Quoted in BioPharma-Reporter.com Article Entitled, "Trump, TPP and America First threaten US biomanufacturing jobs, says expert"

Kevin E. Noonan, Ph.D.January 27, 2017

McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Kevin Noonan is quoted in a January 27, 2017 online edition of BioPharma-Reporter.com in an article entitled, “Trump, TPP and America First threaten US biomanufacturing jobs, says expert.” Donald Trump’s withdrawal from the Trans-Pacific Partnership (TPP) could end up benefitting Asian biosimilar makers and reducing US jobs, says an IP lawyer. View the article